Trifluridine Tipiracil,Bevacizumab,capecitabine
Pfizer,roche
['crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'capecitabine', 'bevacizumab']
 based on [these findings], capecitabine/bevacizumab is still the standard in this population in the frontline setting, bassel el-rayes, md. #crcsm #asco23 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.